The use of solvents in the intestinal manifestations of mucoviscidosis.
D003550:Cystic Fibrosis / Q000150:complications*; D006801:Humans; D007231:Infant, Newborn; D007415:Intestinal Obstruction / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery; D008297:Male; D008470:Meconium; D012997:Solvents / Q000627:therapeutic use*; D013501:Surface-Active Agents / Q000627:therapeutic use*
D012997:Solvents; D013501:Surface-Active Agents